We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This guide is to help you and your business understand how to establish a safe environment for children to positively interact with each other.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
How to use a cost benefit analysis to evaluate your digital health product.
How to use a factorial randomised controlled trial to evaluate your digital health product.
Find out about the long-term effects some people can have after having COVID-19.
These publications provide analyses and data that are not classified as research or official statistics.
We are producing guidance and information for industry, healthcare professionals and patients covering the coronavirus (COVID-19) outbreak.
Information to support your recovery after COVID-19.
This guide explains how impacts on noise should be incorporated into a cost benefit analysis.
How to use an interrupted time series to evaluate your digital health product.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
There is a risk of harmful drug interactions with the ritonavir component of the COVID-19 treatment Paxlovid▼ due to its inhibition of the enzyme CYP3A, which metabolises many commonly used drugs. Prescribers should obtain a detailed patient history of current...
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Information about COVID-19 and pregnancy from the Royal College of Obstretricians and Gynaecologists (RCOG).
We help people, businesses and the UK economy by promoting competitive markets and tackling unfair behaviour. CMA is a non-ministerial department.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.